The research behind PROUROL

Probiotic-first bladder wellness. Urinary microbiome science. Thoughtful daily urinary tract support.

At Sunn Biolabs, every formulation begins with peer-reviewed evidence and a clear understanding of what is actually in the product. PROUROL is a daily bladder wellness supplement built around a 10 billion CFU multi-strain probiotic blend plus D-mannose. It is designed to support bladder wellness, urinary tract health, and a healthy urinary microbiome.

PROBIOTIC-FIRST | MICROBIOME-INFORMED | DAILY BLADDER WELLNESS

Cleveland Clinic · UCLA · Cedars-Sinai · Queen's University · Providence · Keck Medicine of USC

Members of our Medical Advisory Board and formulation consultants hold academic and clinical appointments at these institutions.

ON THIS PAGE

• Modern bladder health
• The urinary microbiome
• Why PROUROL uses six probiotic strains
• The research behind the formula
• Why these ingredients were combined
• Daily bladder wellness
• Full references

Modern bladder health

Healthy urinary function involves more than avoiding infection.

Bladder wellness is part of a larger biological system that includes the bladder lining, urinary tract environment, hydration patterns, immune signaling, hormonal changes, the gastrointestinal microbiome, and the microbial communities that may be present in the lower urinary tract. Modern bladder health research is increasingly focused on how these systems interact over time.

This broader view matters because urinary comfort and healthy urinary function are not defined only by the absence of infection. A person may be thinking about bladder wellness because of daily routines, age-related changes, hydration habits, urogenital microbial balance, or general urinary tract support. PROUROL was designed for that daily wellness context.

The goal is conservative and specific: PROUROL is formulated to support urinary tract health and help maintain a healthy urinary microbiome as part of a long-term bladder wellness routine.

The urinary microbiome

One of the most important shifts in bladder science is the recognition that urine is not always sterile.

For many years, standard medical teaching described urine in healthy people as sterile. That view changed as researchers began using enhanced culture methods and DNA-based sequencing tools. Studies using expanded quantitative urine culture and 16S rRNA sequencing demonstrated that bacterial communities can be detected in catheterized urine samples from adult women, even when standard clinical cultures report "no growth" [1][2].

Researchers now often refer to this microbial community as the urinary microbiome, or urobiome. The science is still developing, and findings can vary by age, sex, hormone status, collection method, symptoms, and study design. Still, the overall shift is clear: bladder health research now considers microbial balance as one part of urinary wellness.

Several studies have reported that Lactobacillus species are common in many healthy female urogenital and urinary microbiome profiles, while other microbial patterns have been associated with different bladder-health measures or lower urinary tract symptoms [2][3]. These findings do not mean that probiotics treat disease. They do provide a modern scientific framework for why a probiotic-first bladder wellness formula is a thoughtful direction for daily urinary support.

A careful interpretation. Urinary microbiome research is exciting, but it is not a finished field. The presence of a bacterial genus in a healthy microbiome does not prove that taking that organism as a supplement will produce a specific clinical outcome. PROUROL is therefore positioned as a dietary supplement that supports urinary wellness and healthy microbial balance, not as a treatment or prevention product.

Why PROUROL uses six probiotic strains

The six-strain probiotic blend is the heart of the current formula.

PROUROL supplies a 10 billion CFU multi-strain probiotic blend that includes Lactobacillus casei, Lactobacillus paracasei, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus rhamnosus, and Bifidobacterium lactis.

A multi-strain design was chosen because microbial ecosystems are not built around a single organism. Different probiotic species have been studied for different characteristics within the gastrointestinal, vaginal, and urogenital microbiomes, including interactions with epithelial surfaces, production of organic acids, competitive adhesion, immune signaling, and support for microbial balance.

PROUROL does not assign unsupported bladder benefits to each individual strain. Instead, the formula reflects a broader formulation philosophy: use a diverse, complementary probiotic blend to support the body's microbial ecology as part of daily urinary tract wellness.

Lactobacillus species

Lactobacillus species are central to much of the urogenital microbiome literature. They are frequently discussed in relation to vaginal and urinary microbial balance, and several probiotic trials have evaluated Lactobacillus strains in urinary-health contexts. Trial results have been mixed and are often strain-specific, which is why PROUROL describes this evidence cautiously [4][5].

Bifidobacterium lactis

Bifidobacterium species are widely studied in human probiotic research, especially in relation to digestive health, immune signaling, and microbial balance. Including Bifidobacterium lactis broadens the probiotic blend beyond Lactobacillus alone and supports the formulation's microbiome-first design.

The research behind the formula

PROUROL is best understood as a complete bladder wellness formula, not a single-ingredient story.

Multi-strain probiotic blend

The strongest scientific rationale for PROUROL begins with the urinary microbiome itself. Enhanced culture and sequencing studies have shown that the lower urinary tract can contain resident microbial communities, and Lactobacillus-dominant profiles are often discussed as part of healthy urogenital microbial ecology [1][2][3].

Human probiotic research in urinary health has generally studied specific strains rather than the exact PROUROL blend. For example, a randomized trial of oral Lactobacillus rhamnosus GR-1 plus Lactobacillus reuteri RC-14 in postmenopausal women with recurrent urinary tract infections found that the probiotic approach did not meet the study's noninferiority margin compared with antibiotic prophylaxis, but it also did not increase antibiotic resistance [4]. Intravaginal Lactobacillus crispatus has also been evaluated in a phase 2 trial in women with recurrent urinary tract infections [5].

These studies do not prove that PROUROL prevents urinary tract infections, and they used different strains and delivery methods. They do support the broader scientific concept that probiotic species, especially Lactobacillus, are relevant to urogenital microbial balance and worthy of continued study.

D-Mannose

D-mannose is a simple sugar that has been widely studied in urinary-health research. It has been investigated because of its proposed relationship to bacterial adhesion in the urinary tract. The evidence base is mixed, and the most responsible interpretation is cautious.

Earlier studies and reviews suggested that D-mannose might be useful in some urinary-health contexts, but a 2022 Cochrane review concluded that evidence was insufficient to determine whether D-mannose was effective for preventing or treating urinary tract infections [6]. A large 2024 randomized clinical trial in JAMA Internal Medicine found no significant reduction in medically attended suspected urinary tract infections with 2 grams daily D-mannose compared with placebo in women with recurrent urinary tract infections [7].

Why D-mannose remains in PROUROL. PROUROL includes 250 mg of D-mannose as a complementary urinary tract support ingredient, not as the primary scientific claim. The main story is the probiotic-first design and support for a healthy urinary microbiome.

Why these ingredients were combined

Healthy bladder function involves multiple biological systems. Rather than relying on one ingredient or one mechanism, PROUROL combines a six-strain probiotic blend with D-mannose in an intentionally formulated daily supplement.

The probiotic blend supports a microbiome-informed approach to bladder wellness. D-mannose contributes a separate urinary tract support pathway that has been studied extensively, even though clinical findings are mixed. Together, these ingredients create a complementary formulation for people seeking daily urinary wellness support.

This is not a claim of synergy, disease prevention, or treatment. It is a formulation choice based on the idea that urinary wellness can be supported through multiple pathways: microbial balance, urinary tract environment, and daily bladder-support routines.

Daily bladder wellness

Many people now use probiotics as part of a daily digestive-health routine. Urinary wellness may be moving in a similar direction as researchers continue exploring the urinary microbiome and the relationship between microbial balance and bladder health.

PROUROL was designed for that daily wellness setting. It is a probiotic-first bladder supplement for people who want to support urinary tract health, healthy urinary function, and a healthy urinary microbiome over time.

If you have burning with urination, fever, pelvic pain, blood in the urine, new or worsening urinary symptoms, recurrent infections, or any concern about an active medical condition, seek care from a qualified healthcare professional. Dietary supplements are not a substitute for diagnosis or treatment.

Full references

All citations are peer-reviewed and PubMed-indexed or published in major scientific journals. The references below support the educational discussion on urinary microbiome science, probiotic research, and D-mannose evidence. They do not constitute clinical evidence that PROUROL as a finished product diagnoses, treats, cures, or prevents disease.

1. Hilt EE, McKinley K, Pearce MM, et al. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol. 2014;52(3):871-876. PMID: 24371246
2. Pearce MM, Hilt EE, Rosenfeld AB, et al. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio. 2014;5(4):e01283-14. PMID: 25006228
3. Price TK, Wolfe AJ, Mueller ER, et al. Bladder health and the urogenital microbiome in community-dwelling adult females. mSystems. 2025. ASM Journals
4. Beerepoot MAJ, ter Riet G, Nys S, et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med. 2012;172(9):704-712. PMID: 22782199
5. Stapleton AE, Au-Yeung M, Hooton TM, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis. 2011;52(10):1212-1217. PMID: 21498386
6. Cooper TE, Teng C, Howell M, Teixeira-Pinto A, Jaure A, Wong G. D-mannose for preventing and treating urinary tract infections. Cochrane Database Syst Rev. 2022;8(8):CD013608. PMID: 36041061
7. Hayward G, Mort S, Yu LM, et al. D-mannose for prevention of recurrent urinary tract infection among women: a randomized clinical trial. JAMA Intern Med. 2024;184(6):619-628. PMID: 38587819

These statements have not been evaluated by the Food and Drug Administration. PROUROL is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease, including urinary tract infections. Individual results may vary. The peer-reviewed research cited on this page summarizes urinary microbiome science, individual ingredients, related probiotic approaches, and studies that used different probiotic strains or delivery methods than PROUROL. It does not constitute clinical evidence specific to PROUROL as a finished product. Consult your healthcare provider before starting any new dietary supplement, particularly if you are pregnant or nursing, have urinary symptoms, have recurrent urinary tract infections or other urologic conditions, have a compromised immune system, or take prescription medications. It is not intended for acute urinary symptoms, and it is not a substitute for medical evaluation or treatment.